NO20053612L - 1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet - Google Patents

1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet

Info

Publication number: NO20053612L
Authority: NO; Norway
Prior art keywords: treatment; nervous system; central nervous; system disorders; derivatives useful
Prior art date: 2002-12-27

Application number

NO20053612A

Other languages

English (en)

Norwegian (no)

Other versions

NO20053612D0 (no

Inventor

Mario Rottlander

Morten Bang Norgaard

Christian Wenzel Tornoe

Andreas Ritzen

Nikolay Khanzhin

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-27

Filing date

2005-07-25

Publication date

2005-09-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35295526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20053612(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-12-18 Priority claimed from PCT/DK2003/000906 external-priority patent/WO2004058739A1/en

2005-07-25 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2005-07-25 Publication of NO20053612D0 publication Critical patent/NO20053612D0/no

2005-09-23 Publication of NO20053612L publication Critical patent/NO20053612L/no

Links

JSYBAZQQYCNZJE-UHFFFAOYSA-N benzene-1,2,4-triamine Chemical class NC1=CC=C(N)C(N)=C1 JSYBAZQQYCNZJE-UHFFFAOYSA-N 0.000 title abstract 2
208000015114 central nervous system disease Diseases 0.000 title 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20053612A 2002-12-27 2005-07-25 1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet NO20053612L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200202012		2002-12-27
PCT/DK2003/000906 WO2004058739A1 (en)	2002-12-27	2003-12-18	1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system

Publications (2)

Publication Number	Publication Date
NO20053612D0 NO20053612D0 (no)	2005-07-25
NO20053612L true NO20053612L (no)	2005-09-23

Family

ID=35295526

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20053612A NO20053612L (no)	2002-12-27	2005-07-25	1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet

Country Status (16)

Country	Link
KR (1)	KR20050089862A (pl)
CN (1)	CN100448867C (pl)
AR (1)	AR042656A1 (pl)
BR (1)	BR0317748A (pl)
CL (1)	CL2003002748A1 (pl)
EA (1)	EA008589B1 (pl)
IS (1)	IS2649B (pl)
MY (1)	MY139844A (pl)
NO (1)	NO20053612L (pl)
PE (1)	PE20041015A1 (pl)
PL (1)	PL377221A1 (pl)
SI (1)	SI1578740T1 (pl)
TW (1)	TWI325414B (pl)
UA (1)	UA79666C2 (pl)
UY (1)	UY28151A1 (pl)
ZA (1)	ZA200504565B (pl)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4200259A1 (de) *	1992-01-08	1993-07-15	Asta Medica Ag	Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
DE19539861A1 (de) *	1995-10-26	1997-04-30	Asta Medica Ag	Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
GB9915414D0 (en) *	1999-07-01	1999-09-01	Glaxo Group Ltd	Medical use
US6117900A (en) *	1999-09-27	2000-09-12	Asta Medica Aktiengesellschaft	Use of retigabine for the treatment of neuropathic pain
US6589986B2 (en) *	2000-12-20	2003-07-08	Wyeth	Methods of treating anxiety disorders

2003
- 2003-12-18 BR BR0317748-3A patent/BR0317748A/pt not_active IP Right Cessation
- 2003-12-18 TW TW092135930A patent/TWI325414B/zh not_active IP Right Cessation
- 2003-12-18 EA EA200501053A patent/EA008589B1/ru not_active IP Right Cessation
- 2003-12-18 KR KR1020057012183A patent/KR20050089862A/ko not_active Ceased
- 2003-12-18 SI SI200330827T patent/SI1578740T1/sl unknown
- 2003-12-18 UA UAA200507206A patent/UA79666C2/uk unknown
- 2003-12-18 CN CNB2003801076953A patent/CN100448867C/zh not_active Expired - Fee Related
- 2003-12-18 PL PL377221A patent/PL377221A1/pl unknown
- 2003-12-22 AR ARP030104782A patent/AR042656A1/es unknown
- 2003-12-24 CL CL200302748A patent/CL2003002748A1/es unknown
- 2003-12-24 UY UY28151A patent/UY28151A1/es not_active Application Discontinuation
- 2003-12-26 MY MYPI20035008A patent/MY139844A/en unknown
2004
- 2004-01-05 PE PE2004000037A patent/PE20041015A1/es not_active Application Discontinuation
2005
- 2005-05-23 IS IS7856A patent/IS2649B/is unknown
- 2005-06-03 ZA ZA200504565A patent/ZA200504565B/xx unknown
- 2005-07-25 NO NO20053612A patent/NO20053612L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
TW200413280A (en)	2004-08-01
ZA200504565B (en)	2006-08-30
NO20053612D0 (no)	2005-07-25
EA008589B1 (ru)	2007-06-29
CN1732162A (zh)	2006-02-08
BR0317748A (pt)	2005-11-22
IS2649B (is)	2010-08-15
TWI325414B (en)	2010-06-01
AR042656A1 (es)	2005-06-29
UA79666C2 (en)	2007-07-10
KR20050089862A (ko)	2005-09-08
SI1578740T1 (sl)	2007-08-31
IS7856A (is)	2005-05-23
CL2003002748A1 (es)	2005-04-08
CN100448867C (zh)	2009-01-07
HK1088317A1 (zh)	2006-11-03
MY139844A (en)	2009-11-30
PE20041015A1 (es)	2005-01-08
EA200501053A1 (ru)	2005-12-29
PL377221A1 (pl)	2006-01-23
UY28151A1 (es)	2004-07-30

Similar Documents

Publication	Publication Date	Title
CY1106645T1 (el)	2012-01-25	Παραγωγα 1,2,4 τριαμινοβενζολης χρησιμα για τη θεραπευτικη αντιμετωπιση διαταραχων του κεντρικου νευρικου συστηματος
NO20044501L (no)	2005-01-18	[1,4] diazenino [6,7,1-IJ] kinolin-derivater som antipsykotis og antifedme-midler
NO20073465L (no)	2002-12-12	Benzotiazol-derivater
TNSN05045A1 (en)	2007-05-14	Indole or benzimidazole derivatives for modulating ikappab kinase
NO20054848L (no)	2005-10-20	Substituerte p-diaminobenzenderivater
NO20021328L (no)	2002-05-21	Pyrazolopyrimidier som terapeutiske midler
CY1109558T1 (el)	2014-08-13	Παραγωγα βενζο[d]αζεπινης για την θεραπεια νευρολογικων διαταραχων
PT1147110E (pt)	2003-09-30	Derivados de pirazino (aza)-indol
NO20050851L (no)	2005-03-29	Kaspase-inhibitorer og anvendelser derav
ATE524169T1 (de)	2011-09-15	Therapeutische strategien für die prävention und behandlung der alzeheimer-krankheit
NO20064599L (no)	2006-12-08	Substituerte morfolin- og tiomorfolinderivater
NO20030724D0 (no)	2003-02-14	Anvendelse av derivater av valproinsyreamider og 2- valproensyreamider for terapi eller prevensjon av smerte- og/eller hodepinelidelser
FI113767B (fi)	2004-06-15	Bentsimidatsolijohdannaisia, joilla on dopaminergistä vaikutusta keskushermostossa
NO20060020L (no)	2006-03-03	3-fluorpiperidiner som NMDA/NR2B-antagonister
ATE389655T1 (de)	2008-04-15	Pyrimidinderivate
NO20052698L (no)	2005-06-06	4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gasatrintestinale lidelser.
FI970469A0 (fi)	1997-02-04	Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus
MXPA05004273A (es)	2005-10-18	Derivados de fenilalquil y piridilalquil piperazina.
NO20052699L (no)	2005-06-06	4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
NO20071466L (no)	2007-04-19	3-substituerte-5- og 6-aminoalkyl indol-2-karboksylsyreamider og relaterte analoger som inhibitorer av kaseinkinase IE
NO20062599L (no)	2006-06-06	Fremgangsmate for syntese av perindopril og farmasoytisk akseptable salter derav
NO20054721L (no)	2005-10-13	Substituerte anilinderivater
ATE298742T1 (de)	2005-07-15	Zykloalkenylsulfonamidderivate
DE502004007387D1 (de)	2008-07-31	Triazolverbindungen und ihre therapeutische verwendung
NO20055758L (no)	2005-12-07	Heteroarylsubstituerte imidazolderivater som glutamatreseptorantagonister

Legal Events

Date	Code	Title	Description
2008-07-14	CREP	Change of representative	Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104
2011-07-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application